Tumor-associated natural killer cells have elevated expression of the checkpoint inhibitory receptor TIGIT. Monoclonal antibody–mediated blockade targeting TIGIT unleashes the anti-tumor activity of both natural killer cells and T cells in preclinical mouse models and efficiently delays tumor growth.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment
Nature Communications Open Access 08 December 2020
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
Purchase on Springer Link
Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Zhang, Q. et al. Nat. Immunol. https://doi.org/10.1038/s41590-018-0132-0 (2018)
Blake, S. J., Dougall, W. C., Miles, J. J., Teng, M. W. & Smyth, M. J. Clin. Cancer Res. 22, 5183–5188 (2016).
Stanietsky, N. et al. Proc. Natl Acad. Sci. USA 106, 17858–17863 (2009).
Johnston, R. J. et al. Cancer Cell 26, 923–937 (2014).
Yu, X. et al. Nat. Immunol. 10, 48–57 (2009).
Cerwenka, A. & Lanier, L. L. Nat. Rev. Immunol. 16, 112–123 (2016).
Chiossone, L., Vienne, M., Kerdiles, Y. M. & Vivier, E. Semin. Immunol. 31, 55–63 (2017).
Stojanovic, A., Fiegler, N., Brunner-Weinzierl, M. & Cerwenka, A. J. Immunol. 192, 4184–4191 (2014).
Della Chiesa, M. et al. Front. Immunol 7, 351 (2016).
Stojanovic, A., Correia, M. P. & Cerwenka, A. Cancer Microenviron 6, 135–146 (2013).
Blake, S. J. et al. Cancer Discov 6, 446–459 (2016).
Garrido, F., Aptsiauri, N., Doorduijn, E. M., Garcia Lora, A. M. & van Hall, T. Curr. Opin. Immunol. 39, 44–51 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
A.C. is a member of the scientific advisory board of Dragonfly Therapeutics.
Rights and permissions
About this article
Cite this article
Stojanovic, A., Cerwenka, A. Checkpoint inhibition: NK cells enter the scene. Nat Immunol 19, 650–652 (2018). https://doi.org/10.1038/s41590-018-0142-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-018-0142-y
This article is cited by
-
Targeting of the tumor immune microenvironment by metformin
Journal of Cell Communication and Signaling (2022)
-
Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment
Nature Communications (2020)